Intrathecal Delivery of Viruses in a Mouse Model for Treating Central Nervous System Diseases
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 3:33 min • June 17th, 2025
Loading...
Overview
This article describes a protocol for intrathecal delivery of adeno-associated viruses (AAV) in mice, aimed at enabling targeted gene expression. The method involves precise anatomical localization and injection techniques to ensure effective delivery of the viral vector into the cerebrospinal fluid.
Key Study Components
Area of Science
- Neuroscience
- Gene Therapy
- Animal Models
Background
- Adeno-associated viruses are used for gene delivery in various neurological studies.
- Intrathecal delivery allows for direct access to the central nervous system.
- Lidocaine is utilized to temporarily block nerve signals during the procedure.
- Understanding the technique is crucial for researchers working with CNS diseases.
Purpose of Study
- To establish a reliable method for intrathecal delivery of AAV in mice.
- To confirm the effectiveness of the delivery through observable physiological responses.
- To provide a detailed protocol for researchers in the field.
Methods Used
- Preparation of the viral solution and syringe.
- Positioning and preparation of the mouse for injection.
- Identification of the intervertebral space for needle insertion.
- Injection of the viral solution and monitoring of physiological responses.
Main Results
- Successful entry into the intrathecal space was confirmed by a tail flick response.
- Effective distribution of the viral particles within the cerebrospinal fluid.
- Short-term leg paralysis was observed, indicating successful delivery.
- The protocol demonstrated reliability for future gene therapy applications.
Conclusions
- Intrathecal delivery is an effective method for gene therapy in CNS research.
- The procedure can be adapted for various experimental designs.
- Further studies may explore long-term effects and applications of AAV delivery.
Frequently Asked Questions
What is the purpose of using adeno-associated viruses?
AAVs are used for targeted gene delivery in neurological studies.
How is the mouse prepared for the injection?
The mouse is placed in a prone position, and its lower back is shaved and sterilized.
What indicates successful needle entry into the intrathecal space?
A tail flick response confirms successful entry into the intradural space.
What role does lidocaine play in this procedure?
Lidocaine temporarily blocks nerve signals to facilitate the injection process.
How long should the needle remain in the intradural space after injection?
The needle should remain in place for one minute after injecting the solution.
What are the implications of this delivery method?
This method establishes a reliable approach for gene therapy targeting CNS diseases.
Executive Industry Relevance
Intrathecal delivery of adeno-associated viruses enables targeted gene expression in the central nervous system, supporting preclinical validation of CNS therapeutics. This method provides a reproducible route for assessing viral vector biodistribution and transgene expression in vivo, facilitating early-stage target validation and mechanistic de-risking. By confirming delivery via physiological readouts such as tail flick response, the approach offers a quantifiable endpoint for go/no-go decisions in gene therapy pipeline advancement.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses through targeted gene delivery to CNS neurons.
- Operational Value: Supports functional target validation by confirming vector access to the intrathecal space and subsequent transgene expression.
- Predictive Value: Provides mechanistic de-risking by demonstrating reliable CNS delivery prior to therapeutic efficacy testing.
Screening & Assay Development
- Assay Readiness: Establishes a standardized surgical procedure for preparing validated biological systems for downstream transgene expression analysis.
- Quantitative Outputs: Enables measurement of viral distribution in cerebrospinal fluid and neuronal transduction efficiency as dependent variables.
- Reproducibility: The protocol’s reliance on anatomical landmarks and physiological confirmation (tail flick) supports inter-operator consistency and assay standardization.
Translational & Preclinical Research
- Disease-Relevant System: Uses adult mice to model CNS delivery, aligning with preclinical studies of neurological disorders.
- Translational Continuity: Bridges discovery-stage vector optimization with preclinical validation by confirming delivery to the target compartment.
- Risk-Adjusted Advancement: Successful intrathecal delivery, confirmed by lidocaine-induced leg paralysis, supports progression to efficacy studies in disease models.
Pipeline & Workflow Integration
The method fits within the discovery-to-preclinical continuum, supporting lead identification through validation of CNS delivery before advancing to therapeutic efficacy studies.
- Discovery Biology: Supports hypothesis testing by enabling precise gene delivery to CNS circuits for pathway clarification and target de-risking.
- Screening: Delivers assay-ready samples with confirmed intrathecal placement, enabling reliable evaluation of vector constructs.
- Analytics: Generates quantitative dependent variables such as transgene expression levels and viral particle distribution in CSF for comparative condition analysis.
- Translational Research: Connects vector optimization to preclinical continuity by confirming delivery to the CNS, a prerequisite for efficacy testing in disease models.
- Enterprise Reuse: The standardized surgical and injection protocol can be reused across multiple vector serotypes and payloads, supporting platform scalability.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in CNS delivery, reduction of mechanistic ambiguity in vector biodistribution.
- Operational Value: Standardized, reproducible procedure with clear anatomical and physiological endpoints.
- Strategic Value: Informs go/no-go decisions by confirming target engagement, reducing late-stage biological risk in gene therapy programs.
- Portfolio Impact: Enables risk-adjusted prioritization of AAV constructs based on demonstrated CNS delivery efficiency.
Implementation Considerations
- Requires expertise in rodent neurosurgery and aseptic technique to ensure consistent intrathecal access.
- Dependent on precision instrumentation such as Hamilton syringes and 27-gauge needles for accurate volumetric delivery.
- Necessitates cross-team standardization between surgery, vector preparation, and analytics groups to maintain procedural fidelity.
- Adaptation across model systems may require adjustments to needle size, injection volume, and anatomical landmarks based on species-specific spinal anatomy.
- Practical limitations include operator-dependent variability in needle placement and the transient nature of lidocaine-induced physiological readouts.
Biopharma FAQs
Why does tail flick response matter for target validation?
The tail flick response confirms successful needle entry into the intrathecal space, serving as a physiological readout for accurate delivery of viral vectors to the cerebrospinal fluid. This observable endpoint supports target validation by verifying that the vector reaches the intended CNS compartment before assessing transgene expression.
How does isolating the intervertebral space fit the discovery pipeline?
Precise identification of the L5-L6 intervertebral space via palpation and skin indentation ensures accurate needle placement for intrathecal delivery. This procedural control enables reliable CNS access, which is essential for evaluating vector biodistribution and transgene expression in early-stage target validation studies.
What do quantitative dependent variable measurements enable?
Measurements such as viral genome copies in cerebrospinal fluid and transgene expression levels in neurons enable comparison of different AAV constructs or dosing conditions. These quantitative outputs support lead identification by providing measurable criteria for assessing delivery efficiency and biological activity.
Why do replication requirements matter for cross-functional collaboration?
Replication of the intrathecal delivery procedure across operators and experiments ensures consistent vector delivery, which is critical for generating comparable data across biology, vector engineering, and analytics teams. Standardized replication reduces variability and strengthens confidence in go/no-go decisions during preclinical development.
What statistical analysis capabilities are required before implementation?
Before implementation, teams must establish baseline variability in delivery success rates using physiological endpoints like tail flick frequency and leg paralysis duration. Statistical analysis of these outcomes enables power calculations for group sizing and threshold setting for delivery success, ensuring adequate sensitivity to detect differences between vector preparations.
08:32
Subpial Adeno-associated Virus 9 (AAV9) Vector Delivery in Adult Mice
Related Videos
0 Views
07:17
A Minimally Invasive, Accurate, and Efficient Technique for Intrathymic Injection in Mice
Related Videos
0 Views
04:38
Intrathecal Vector Delivery in Juvenile Rats via Lumbar Cistern Injection
Related Videos
0 Views
05:55
Delivery of Therapeutic Agents Through Intracerebroventricular (ICV) and Intravenous (IV) Injection in Mice
Related Videos
0 Views
03:33
Intranasal Delivery of Therapeutic Neural Stem Cells (NSCs) in Murine Model: A Procedure for Tumor-targeted Delivery of Oncolytic Virus Loaded NSCs into Brain Tumor Bearing Mouse Model
Related Videos
0 Views
05:04
Intrathecal Delivery of a Test Compound to the Rat Central Nervous System
Related Videos
0 Views
08:39
Stereotaxic Injection of a Viral Vector for Conditional Gene Manipulation in the Mouse Spinal Cord
Related Videos
0 Views
10:15
Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
Related Videos
0 Views
05:17
Intravenous Injections in Neonatal Mice
Related Videos
0 Views
08:17
Direct Intrathecal Injection of Recombinant Adeno-associated Viruses in Adult Mice
Related Videos
0 Views
Last updated: 27 June 2026